Cargando…

Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system

Recent advances in molecular biology have led to the CRISPR revolution, but the lack of an efficient and safe delivery system into cells and tissues continues to hinder clinical translation of CRISPR approaches. Polymeric vectors offer an attractive alternative to viruses as delivery vectors due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Keeffe Ahern, Jonathan, Lara-Sáez, Irene, Zhou, Dezhong, Murillas, Rodolfo, Bonafont, Jose, Mencía, Ángeles, García, Marta, Manzanares, Darío, Lynch, Jennifer, Foley, Ruth, Xu, Qian, Sigen, A, Larcher, Fernando, Wang, Wenxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013665/ https://www.ncbi.nlm.nih.gov/pubmed/34363036 http://dx.doi.org/10.1038/s41434-021-00282-6

Ejemplares similares

Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
por: García, Marta, et al.
Publicado: (2022)

Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing
por: Bonafont, Jose, et al.
Publicado: (2019)

Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome
por: Gálvez, Victoria, et al.
Publicado: (2020)

Guanidyl-Rich Poly(β Amino Ester)s for Universal Functional Cytosolic Protein Delivery and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Ribonucleoprotein Based Gene Editing
por: Wang, Xianqing, et al.
Publicado: (2023)

Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells
por: Mencía, Ángeles, et al.
Publicado: (2018)

The transition from linear to highly branched poly(β-amino ester)s: Branching matters for gene delivery
por: Zhou, Dezhong, et al.
Publicado: (2016)

Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
por: Bonafont, Jose, et al.
Publicado: (2021)

CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa
por: Wang, Xianqing, et al.
Publicado: (2023)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
por: Kim, Dongyoon, et al.
Publicado: (2020)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
por: Chamorro, Cristina, et al.
Publicado: (2016)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
por: Kazemian, Pardis, et al.
Publicado: (2022)

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
por: Sinclair, Frazer, et al.
Publicado: (2023)

Highly branched poly(β-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells
por: Liu, Shuai, et al.
Publicado: (2019)

CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
por: Zhang, Xiaoping, et al.
Publicado: (2019)

Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells
por: Hindriksen, Sanne, et al.
Publicado: (2017)

CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation
por: Sun, Wujin, et al.
Publicado: (2020)

Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing
por: Naeem, Muhammad, et al.
Publicado: (2021)

Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
por: Lohia, Aayushi, et al.
Publicado: (2022)

Strategies for delivery of CRISPR/Cas-mediated genome editing to obtain edited plants directly without transgene integration
por: Kocsisova, Zuzana, et al.
Publicado: (2023)

Branch Unit Distribution Matters for Gene Delivery
por: Li, Yinghao, et al.
Publicado: (2023)

Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing
por: Chaverra-Rodriguez, Duverney, et al.
Publicado: (2018)

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
por: Wei, Tuo, et al.
Publicado: (2020)

Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing
por: Lyu, Pin, et al.
Publicado: (2020)

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
por: Dong, Wendy, et al.
Publicado: (2021)

High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
por: Neil, Kevin, et al.
Publicado: (2021)

Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
por: Meneghini, Vasco, et al.
Publicado: (2021)

Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells
por: Lotfi, Malihe, et al.
Publicado: (2023)

Artificial Intelligence (AI)-Aided Structure Optimization for Enhanced Gene Delivery: The Effect of the Polymer Component Distribution (PCD)
por: Li, Yinghao, et al.
Publicado: (2023)

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
por: Wang, Hong-Xia, et al.
Publicado: (2018)

Biolistic-delivery-based transient CRISPR/Cas9 expression enables in planta genome editing in wheat
por: Hamada, Haruyasu, et al.
Publicado: (2018)

Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing
por: Yin, Hang, et al.
Publicado: (2020)

Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing
por: Liu, Shuai, et al.
Publicado: (2021)

Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
por: Zhang, Xianming, et al.
Publicado: (2022)

Highly Efficient Genome Editing in Plant Protoplasts by Ribonucleoprotein Delivery of CRISPR-Cas12a Nucleases
por: Zhang, Yingxiao, et al.
Publicado: (2022)

Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing
por: Xiu, Kemao, et al.
Publicado: (2022)

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
por: Khoshandam, Mohadeseh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_incfl0tr8eqtcel6jtpltrs457